Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment.
ACS Medicinal Chemistry Letters November 14, 2024 DOI: 10.1021/acsmedchemlett.4c00490 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Patent review Peer reviewed |
|---|---|
| Interventions | 5-MeO-DMT DMT |
| Topics | Psychedelic-assisted therapy 5-MeO-DMT DMT |
| Keywords | Alternative medicine Depression treatment Therapeutic compounds Mental health treatment |
| Citations | 3 |
| Key findings | Recent patents describe innovative strategies for using 5-MeO-DMT and DMT to treat severe psychiatric conditions, including combination with mood preparation agents, prodrug formulations, and tailored therapies for specific populations. |
Abstract
Recent advancements in the therapeutic use of psychedelic compounds, particularly 5-MeO-DMT and DMT, have demonstrated significant potential in treating various mental health disorders. This Patent Highlight evaluates findings from multiple recent patents that explore novel applications of these compounds, including their use in severe psychiatric conditions such as depression, anxiety, and trauma-related disorders. The patents reveal innovative strategies, such as combining 5-MeO-DMT with mood preparation agents to enhance safety and efficacy, developing DMT prodrugs for improved pharmacokinetics, and targeting specific populations like breastfeeding mothers with tailored psychedelic therapies. These advancements offer new hope for patients with treatment-resistant mental disorders, highlighting the evolving role of psychedelics in mental health care.